๐ฐ Scientific Statement From News
Page 4 - Scientific Statement From News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientific Statement From. Real-time updates on events, politics, business and more.
April 5, 2023
The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Associationโs Hypertension journal.
March 30, 2023
The latest scientific statement from the American Heart Association takes aim at offering clinicians with a summary of contemporary evidence related to the prevalence and increase in long-term risk associated with hypertension in children and adolescents.
February 10, 2023
Is sour cream healthy? Read to learn all about sour cream, its nutritional value, potential health benefits, and any potential risks in 2023.
February 10, 2023
Is sour cream healthy? Read to learn all about sour cream, its nutritional value, potential health benefits, and any potential risks in 2023.
February 10, 2023
Is sour cream healthy? Read to learn all about sour cream, its nutritional value, potential health benefits, and any potential risks in 2023.
January 31, 2023
The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained blood pressure reduction over 48 weeks and was well-tolerated Allschwil
January 4, 2023
On-site care explanations, possible causes, traumatic stress of responders/observers, resources for learning CPR
January 4, 2023
On-site care explanations, possible causes, traumatic stress of responders/observers, resources for learning CPR
December 29, 2022
You probably know the usual heart disease causes: too many pounds, lack of exercise, eating too much fat and salt. But much stranger things can also increase the risk of heart disease.
December 20, 2022
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension